DCUN1D2

Across TCGA pan-cancer cohorts, DCUN1D2 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated DCUN1D2 data layer compared with 29 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher DCUN1D2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DCUN1D2 expression acts as an unfavorable survival marker.

READ, BLCA, and UCEC are the cancer types where DCUN1D2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	II,III,IV	0.111	0.919	<.001	36	view →
BLCA	OS	Median	IV	0.051	0.600	<.001	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

DCUN1D2–READ (OS)

Open the READ breakdown →